Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 3/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24892693 | 0.85 | — | — | |
| SCHEMBL8862265 | 0.81 | TSHR (0.36) | LMNATSHRCA2NFKB1BLM | |
| SCHEMBL28609466 | 0.81 | TGFBR1 (0.42) | LMNATSHRCA2NFKB1BLM | |
| SCHEMBL24463 | 0.80 | — | — | |
| SCHEMBL2448286 | 0.78 | — | — | |
| SCHEMBL1938866 | 0.78 | — | — | |
| SCHEMBL27662 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL11795328 | 0.78 | — | — | |
| SCHEMBL1228638 | 0.78 | NPC1 (0.40) | LMNATSHRCA2NFKB1BLM | |
| SCHEMBL31144892 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1879989-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | Colgate-Palmolive Company (US) | 2008-01-23 | — | — | EP | claimed |
| WO-2006121639-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | COLGATE-PALMOLIVE COMPANY (US) | 2006-11-16 | — | — | WO | claimed |
| EP-1740682-B1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | COLGATE PALMOLIVE CO (US) | 2009-06-24 | — | — | EP | disclosed |
| US-20080076698-A1 | Fabric Care Composition Comprising Polymer Encapsulated Fabric or Skin Beneficiating Ingredient | JACQUES ALAIN | 2008-03-27 | — | — | US | disclosed |
| US-20080076697-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | HEIBEL MARIJA | 2008-03-27 | — | — | US | disclosed |
| US-20080070824-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | HEIBEL MARIJA | 2008-03-20 | — | — | US | disclosed |
| US-20080044390-A1 | Methods and compositions for the treatment of neurodegenerative disorders | CHDI, INCORPORATED | 2008-02-21 | — | — | US | disclosed |
| EP-1879989-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | Colgate-Palmolive Company (US) | 2008-01-23 | — | — | EP | disclosed |
| US-7304026-B2 | Fabric care composition comprising polymer encapsulated fabric or skin beneficiating ingredient | COLGATE-PALMOLIVE COMPANY (US) | 2007-12-04 | — | — | US | disclosed |
| US-20070173433-A1 | Fabric Care Composition Comprising Polymer Encapsulated Fabric or Skin Beneficiating Ingredient | COLGATE-PALMOLIVE COMPANY | 2007-07-26 | — | — | US | disclosed |
| US-7211556-B2 | Fabric care composition comprising polymer encapsulated fabric or skin beneficiating ingredient | COLGATE-PALMOLIVE COMPANY (US) | 2007-05-01 | — | — | US | disclosed |
| EP-1290120-B1 | FABRIC SOFTENING COMPOSITIONS CONTAINING CATIONIC SOFTENERS AND FATTY AMIDES | COLGATE PALMOLIVE CO (US) | 2006-05-17 | — | — | EP | disclosed |
| US-20050256027-A1 | Fabric care composition comprising polymer encapsulated fabric or skin beneficiating ingredient | COLGATE-PALMOLIVE COMPANY | 2005-11-17 | — | — | US | disclosed |
| WO-2005103215-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | COLGATE-PALMOLIVE COMPANY (US) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005103216-A1 | FABRIC CARE COMPOSITION COMPRISING POLYMER ENCAPSULATED FABRIC OR SKIN BENEFICIATING INGREDIENT | COLGATE-PALMOLIVE COMPANY (US) | 2005-11-03 | — | — | WO | disclosed |
| US-20050233939-A1 | Fabric care composition comprising polymer encapsulated fabric or skin beneficiating ingredient | COLGATE-PALMOLIVE COMPANY | 2005-10-20 | — | — | US | disclosed |
| EP-1290120-A2 | FABRIC SOFTENING COMPOSITIONS CONTAINING CATIONIC SOFTENERS AND FATTY AMIDES | Colgate-Palmolive Company (US) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001092446-A2 | FABRIC SOFTENING COMPOSITIONS CONTAINING CATIONIC SOFTENERS AND FATTY AMIDES | COLGATE-PALMOLIVE COMPANY (US) | 2001-12-06 | — | — | WO | disclosed |
| US-6191101-B1 | CATIONIC SURFACTANTS, FATTY AMIDE, POLYSILOXANES AND WATER | COLGATE-PALMOLIVE CO. | 2001-02-20 | — | — | US | disclosed |
| US-3940365-A | PHENOLIC ANTIOXIDANT AND AN UREA OR AN OXALIC ACID DIAMIDE OR AN AZODICARBOXYLIC AMIDE | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080044390-A1 | Methods and compositions for the treatment of neurodegenerative disorders | HTT, SNCA, NLN | LMNA 415/4885TSHR 4669/4885CA2 2424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.